Industries > Pharma > Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

Branded Drugs, Generic Drugs, Leading Companies

PUBLISHED: 03 October 2018
PAGES: 229
PRODUCT CODE: PHA0335
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0335 Categories: , Tags: , , ,

The pharmaceutical wholesale and distribution market is vital, providing access to life saving drugs to vast number of people in a timely manner. The market is large, with many opportunities for growth and development during the forecast period.

The establishment of the pharmaceutical wholesale market was driven by manufacturers wanting to outsource distribution to wholesalers to focus on core competencies of R&D and marketing. At the same time, hospitals outsourced inventory management in an effort to reduce investment in this area. These factors created a high demand for a comprehensive wholesale and distribution service.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 229-page report you will receive 132 charts– all unavailable elsewhere.

The 229-page report provides clear detailed insight into the leading pharmaceutical wholesale & distribution organizations. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical Wholesale & Distribution Market Size in 2017 and forecasts to 2027

• Global Pharmaceutical Wholesale & Distribution Market Size in 2017 and forecasts to 2027 segmented by submarket:
• Branded Drugs
• Generic Drugs
• Others

• A SWOT and STEP analysis of the global pharmaceutical wholesale & distribution market

• Profiles of the 20 leading pharmaceutical wholesale & distribution organizations:
• Alfresa Holdings
• AmerisourceBergen
• Anda Inc.
• Cardinal Health
• CR Pharmaceutical
• CuraScript Special
• Fortissa Limited
• H.D. Smith
• Mawdsley-Brooks & Co. Ltd.
• McKesson
• MEDIPAL HOLDINGS
• Morris & Dickson Co. LLC
• North Carolina Mutual Wholesale Drug
• Prodigy Health
• Shanghai Pharmaceutical Holdings.
• SINOPHARM
• Smith Drug Company
• SUZUKEN
• The PHOENIX Group
• Walgreens Boots AllianceSUZUKEN
• The PHOENIX Group
• Walgreens Boots Alliance

Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018

• The content of each profile differs, depending on the organization. In general, a profile gives the following information:
• Overview of the company’s services and operations
• Analysis of recent financial performance – annual revenue for services, including data on operating profit and margins
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations

Visiongain’s study is intended for anyone requiring commercial analyses for pharmaceutical wholesale & distribution market. You find data, trends and predictions.

Buy our report today Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018: Branded Drugs, Generic Drugs, Leading Companies

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018


Download sample pages

Complete the form below to download your free sample pages for Top 20 Pharmaceutical Wholesale & Distribution Organizations 2018


Latest Pharma news

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2022-2032

The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.

13 September 2022

READ